|
Market Closed -
Toronto S.E.
23:00:00 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 3.900 CAD | +4.56% |
|
+8.33% | -19.09% |
| 08-12 | HLS Therapeutics Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | HLS Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- HLS Stock
- Consensus HLS Therapeutics Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
